We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,990 hedge funds and large institutions have $267B invested in Johnson & Johnson in 2019 Q4 according to their latest regulatory filings, with 373 funds opening new positions, 1,140 increasing their positions, 1,233 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

465% more first-time investments, than exits

New positions opened: 373 | Existing positions closed: 66

22% more funds holding in top 10

Funds holding in top 10: 485592 (+107)

14% more capital invested

Capital invested by funds: $233B → $267B (+$33.7B)

14% more call options, than puts

Call options by funds: $2.66B | Put options by funds: $2.33B

10% more funds holding

Funds holding: 2,7242,990 (+266)

1.21% more ownership

Funds ownership: 68.38%69.59% (+1.2%)

8% less repeat investments, than reductions

Existing positions increased: 1,140 | Existing positions reduced: 1,233

Holders
2,990
Holders Change
+266
Holders Change %
+9.77%
% of All Funds
58.92%
Holding in Top 10
592
Holding in Top 10 Change
+107
Holding in Top 10 Change %
+22.06%
% of All Funds
11.67%
New
373
Increased
1,140
Reduced
1,233
Closed
66
Calls
$2.66B
Puts
$2.33B
Net Calls
+$334M
Net Calls Change
+$537M
Name Holding Trade Value Shares
Change
Change in
Stake
TIM
3001
Tikehau Investment Management
France
-$13.3M -102,640 Closed
BIM
3002
Bogle Investment Management
Massachusetts
-$11.7M -90,449 Closed
Tudor Investment Corp
3003
Tudor Investment Corp
Connecticut
-$8.63M -66,662 Closed
EPFB
3004
Employees Provident Fund Board
Malaysia
-$7M -54,096 Closed
LMIM
3005
Lockheed Martin Investment Management
Maryland
-$6.91M -53,440 Closed
TRCT
3006
Tower Research Capital (TRC)
New York
-$4.81M -37,148 Closed
ECM
3007
Element Capital Management
New York
-$4.79M -37,003 Closed
TI
3008
Trexquant Investment
Connecticut
-$4.68M -36,197 Closed
CIM
3009
Cambria Investment Management
California
-$4.3M -33,266 Closed
6CM
3010
683 Capital Management
New York
-$3.23M -25,000 Closed
GCM
3011
Gladius Capital Management
Illinois
-$2.93M -21,595 Closed
BGDI
3012
BW Gestao de Investimentos
Brazil
-$2.59M -20,000 Closed
ECM
3013
ExodusPoint Capital Management
New York
-$2.38M -18,365 Closed
LFDLE
3014
La Financiere de L'Echiquier
France
-$2.25M -17,430 Closed
QT
3015
Quantbot Technologies
New York
-$2.12M -16,419 Closed
WIM
3016
Waverton Investment Management
United Kingdom
-$2.01M -15,545 Closed
BHWA
3017
Beacon Harbor Wealth Advisors
Virginia
-$1.71M -12,902 Closed
SP
3018
Symmetry Partners
Connecticut
-$1.65M -12,785 Closed
CPP
3019
Crow Point Partners
Massachusetts
-$1.64M -12,744 Closed
PC
3020
PointState Capital
New York
-$1.51M -11,700 Closed
BAM
3021
Blueshift Asset Management
New Jersey
-$1.46M -11,304 Closed
GCA
3022
Gideon Capital Advisors
New York
-$1.44M -11,162 Closed
Group One Trading
3023
Group One Trading
Illinois
-$1.51M -11,159 Closed
HSA
3024
Hussman Strategic Advisors
Maryland
-$1.38M -10,650 Closed
BG
3025
Bellevue Group
Switzerland
-$1.29M -10,000 Closed

JNJ Hedge Fund Activity: Q4 2019 in Review

2,990 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2019, worth a combined $267B — up 14% from $233B a quarter earlier.

Buyers outnumbered sellers: 373 funds opened new JNJ positions and 66 closed out — a net gain of 307 holders — while 1,140 added to existing stakes and 1,233 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $783M. The largest seller was Capital World Investors, cutting an estimated $1.27B.

  • 2,990 institutional investors held Johnson & Johnson (JNJ) as of Q4 2019, up from 2,724 in Q3 2019.
  • Funds reported $267B of Johnson & Johnson stock for Q4 2019, up 14% quarter-over-quarter.
  • 373 funds opened new Johnson & Johnson positions in Q4 2019 and 66 closed out, a net change of +307 holders.
  • The largest Johnson & Johnson buyer in Q4 2019 was JP Morgan Chase, an estimated $783M added.
  • The largest Johnson & Johnson seller in Q4 2019 was Capital World Investors, an estimated $1.27B sold.

Based on aggregated 13F filings for Q4 2019.